Category: Imaging
Imaging
The Food & Drug Administration and Health Canada both cleared a Polish reactor to supply Covidien with scarce molybdenum 99, which the Mansfield, Mass.-based company will use to make the radiological isotope technetium 99.
Covidien (NYSE:COV) won clearance from the Food & Drug Administration and its counterpart north of the border, Health Canada, to begin using a Polish nuclear reactor to supply a scarce medical isotope.
The Mansfield, Mass.-based medical products conglomerate can start using molybdenum 99 from the Polish Institute of Atomic Energy's Maria reactor to make technetium 99, which is used in imaging procedures.
Peabody, Mass.-based imaging equipment maker Analogic Corp. sees sales of its MRI and CT equipment drop 9 percent during the second quarter and cuts 17 jobs, but doubles its bottom line.
Analogic Corp.'s (NSDQ:ALOG) largest business segment posted flat sales, with a 9 percent dip in its bread-and-butter MRI and CT equipment business offsetting stronger sales of specialized ultrasound equipment.
The Peabody, Mass.-based imaging equipment maker posted sales of $103.3 million for the three months ended Jan. 31, essentially flat compared with $102.7 million during the same period last year. Still, net income improved to $3.6 million, compared to $1.4 million for the same period last year, when the company took a $3.5 million hit to its bottom line when it laid off 145 employees, or about 9 percent of its total workforce.
Cambridge, Mass.-based Biospace Med inks a distribution deal with Oldelft Benelux to sell its sterEOS 2D/3D X-ray workstation in Belgium, the Netherlands and Luxembourg.
Biospace Med followed up on some good news stateside with a European distribution deal that will see its full-body, low-radiation X-ray workstation hit the market in the Benelux nations.
The Paris, France-based company, which houses its U.S. headquarters in Cambridge, Mass., inked a deal with Oldelft Benelux to distribute its sterEOS 2D/3D X-ray workstation in Belgium, the Netherlands and Luxembourg.
Newton, Mass.-based Rcadia Medical Imaging wins clearance in the European Union for its algorithm-based diagnostic software to detect signs of coronary artery disease.
Rcadia Medical Imaging Ltd. has received CE Mark approval for its algorithm-based software tool that detects for signs of coronary artery disease.
The Newton, Mass.-based company manufactures the COR Analyzer, which quickly triages patients who come into an emergency room with chest pains to determine if there are signs of coronary artery disease. The software uses an algorithm to rapidly processes images taken during coronary CT angiography (cCTA) studies and produces real-time analysis to determine whether there are lesions in coronary arteries.
The product is specifically for use in emergency departments and radiology settings and functions as an add-on to all models of cCTA machines.
Cambridge, Mass.-based Biospace Med wins 510(k) clearance from the Food & Drug Administration to use its full-body X-ray work station for children with spinal deformations.
Biospace Med won regulatory clearance to use its full-body, low-radiation X-ray workstation for children with spinal problems.
The Paris, France-based company, which houses its U.S. headquarters in Cambridge, Mass., won 510(k) clearance from the Food & Drug Administration to use its sterEOS 2D/3D workstation in pediatric care.
The device, which consists of a scanner and a three-dimensional bone-modeling program, can capture head-to-toe images of patients in a standing, weight-bearing position, which can help orthopedic surgeons determine balance, posture and the position of each vertebra. The company says the workstation enables better assessments for surgical planning.
Researchers in California use CT scanners on a pair of mummified Egyptian crocodiles; Syncardia's Freedom mobile artificial heart driver wins CE Mark; Cook Medical's Hercules 3-stage esophageal balloon hits the market; and EEG used in absurd torture device.
Mummified crocs get tomographed: Conservators from Phoebe A. Hearst Museum at UC Berkeley teamed up with Stanford physicists and clinicians to CT scan two Egyptian crocodile mummies that reside at the museum. Stanford's SCOPE blog is reporting that the crocs were also put through a physics laboratory CT scanner that produces higher resolution images than clinical ones. 
Imaging data management provider Amicas Inc. is leaving private equity firm Thoma Bravo LLC at the altar in favor of a higher offer from Midwestern competitor Merge Healthcare Inc., despite its initial disdain and a $9 million breakup fee.
Amicas Inc. (NSDQ:AMCS) jilted its erstwhile buyer, private equity firm Thoma Bravo LLC, in favor of a higher offer from Merge Healthcare Inc. (NSDQ:MRGE) that it initially met with disdain.